(Q41667301)

6 October 2017

1 reference

title

Recent developments in autoimmune liver diseases (English)

1 reference

6 October 2017

Manns MP

1

1 reference

6 October 2017

1 October 1997

1 reference

Journal of Gastroenterology and Hepatology

6 October 2017

1 reference

6 October 2017

12

1 reference

6 October 2017

9-10

1 reference

6 October 2017

S256-71

1 reference

New challenges in hepatic fibrosis

6 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Anti-liver-kidney microsome antibody type 1 recognizes human cytochrome P450 db1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

B-type cytochromes in plasma membranes isolated from rat liver, in comparison with those of endomembranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Determination of the membrane topology of the phenobarbital-inducible rat liver cytochrome P-450 isoenzyme PB-4 using site-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Association of autoimmune active chronic hepatitis with HL-A1,8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Two-locus involvement in the association of human leukocyte antigen with the extrahepatic manifestations of autoimmune chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

The validity of bioelectrical impedance analysis in estimating total body water in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

A possible association between basic amino acids of position 13 of DRB1 chains and autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Anti-GOR and hepatitis C virus in autoimmune liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Liver/kidney microsome antibody type 1 and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

GBV-C/HGV is not the major cause of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Persistent measles virus genome in autoimmune chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Polyarteritis nodosa and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Immunological disorders in C virus chronic active hepatitis: a prospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Erythropoietic protoporphyria and hepatic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Classification of chronic hepatitis: diagnosis, grading and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Failure of hepatitis B immune globulin to protect against exp infection in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00509.X

10.1111/J.1440-1746.1997.TB00509.X

21 January 2018

Identifiers

DOI

1 reference

6 October 2017

1 reference

PubMed ID

9407346